History <a href="http://www.bsgonline.nl/cyclophosphamide-iv-side-effects-04ec.pdf#damp">cyclophosphamide iv side effects</a>  The IV investor presentation reviewed by Reuters shows that at the end of last year, the average rate of return for IV's 2003 fund was 16.2 percent, while the 2008 fund stood at 2.5 percent. In a court filing in August, Intellectual Ventures said it has earned more than $3 billion to date in licensing fees.